Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06295367 · ClinicalTrials.gov registry record · NA
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
A NA study of Malignant Solid Neoplasm, sponsored by ECOG-ACRIN Cancer Research Group.
- Recruiting
- Registry status
- NA
- Development phase
- 760
- Enrollment target
- 20
- Study locations
NCT06295367 is a NA study of Malignant Solid Neoplasm that is actively recruiting participants, run by ECOG-ACRIN Cancer Research Group. The registered enrollment target is 760 participants, below the 1,137-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (33% lower). The trial reports 20 study locations across 4 states.
The verdict
NCT06295367, a NA study of Malignant Solid Neoplasm, is actively recruiting participants, sponsored by ECOG-ACRIN Cancer Research Group.
- RECRUITING
- Registry status
- NA
- Development phase
- 760 participants
- Enrollment target
- 20
- Study locations
Study Summary
This clinical trial evaluates the effect of Cost Communication and Financial Navigation (CostCOM) intervention on adherence to care and financial burden in cancer patients. Many cancer patients experience financial hardship due to high medical out of pocket costs (OOPC), changes in employment, income and insurance. Financial hardship can lead to a delay or a stop in cancer care, and is linked to poor quality of life. Financial navigation programs, such as CostCOM, provide financial counseling, education and connections to appropriate resources to reduce financial barriers to healthcare and minimize financial stress and burden. CostCOM may improve adherence to care and decrease financial burden in patients with cancer.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Best Practice
- OTHER Interview
- OTHER Financial Navigation
Study Locations (20)
Colorado
- Rocky Mountain Cancer Centers-Aurora - Aurora
- Boulder Community Foothills Hospital - Boulder
- Rocky Mountain Cancer Centers-Boulder - Boulder
- Rocky Mountain Cancer Centers - Centennial - Centennial
- The Women's Imaging Center - Denver
- Colorado Blood Cancer Institute - Denver
- Presbyterian - Saint Lukes Medical Center - Health One - Denver
- Rocky Mountain Cancer Centers-Midtown - Denver
- Rocky Mountain Cancer Centers-Rose - Denver
- Mountain Blue Cancer Care Center - Swedish - Englewood
- Rocky Mountain Cancer Centers - Swedish - Englewood
- The Melanoma and Skin Cancer Institute - Englewood
- Rocky Mountain Cancer Centers-Lakewood - Lakewood
- Rocky Mountain Cancer Centers-Littleton - Littleton
- Rocky Mountain Cancer Centers-Sky Ridge - Lone Tree
Arkansas
- Mercy Hospital Fort Smith - Fort Smith
- CARTI Cancer Center - Little Rock
California
- Contra Costa Regional Medical Center - Martinez
- BASS Medical Group - Lennon - Walnut Creek
Alaska
- Fairbanks Memorial Hospital - Fairbanks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 760 participants |
| Start Date | 2024-02-29 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06295367
The ClinicalTrials.gov registry entry for NCT06295367 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 760 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,137-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (33% lower). The listed sponsor is ECOG-ACRIN Cancer Research Group, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Survey Administration is the first listed.
NCT06295367 reports 20 study locations spanning 4 distinct geographic areas - top geographies include Colorado, Arkansas, California.
Frequently Asked Questions
What is clinical trial NCT06295367 about?
NCT06295367 is a clinical study titled "Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)". This clinical trial evaluates the effect of Cost Communication and Financial Navigation (CostCOM) intervention on adherence to care and financial burden in cancer patients. Many cancer patients experience financial hardship due to high medical out of pocket costs (OOPC), changes in employment, incom...
What is the current status of trial NCT06295367?
This trial is currently recruiting. It is a NA study. The enrollment target is 760 participants. The study started on 2024-02-29. Estimated completion is 2027-12-01.
What conditions does trial NCT06295367 study?
This clinical trial studies the following conditions: Malignant Solid Neoplasm.
What interventions are being tested in trial NCT06295367?
The interventions under investigation include: Survey Administration (OTHER), Best Practice (OTHER), Interview (OTHER), Financial Navigation (OTHER).
Who is sponsoring clinical trial NCT06295367?
This trial is sponsored by ECOG-ACRIN Cancer Research Group, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06295367 being conducted?
This trial has 20 study locations across Alaska, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
RECRUITING · NA
-
Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
RECRUITING · NA
-
Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy
RECRUITING · NA
-
Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting
RECRUITING · NA
-
Community-Based Physical Activity Intervention for Underserved Cancer Survivors
RECRUITING · NA
-
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.